CSBR:NASDAQ
Champions Oncology Inc
4,84 $
arrow_upward
+1,04%(+0,050) 1D
9 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,94 $
High
4,94 $
Low
4,84 $
Mkt. cap
67,37 մլն
Avg. vol.
9,27 հզր
Volume
0,00
52-wk high
8,31 $
52-wk low
4,63 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
Open
4,94 $
High
4,94 $
Low
4,84 $
Mkt. cap
67,37 մլն
Avg. vol.
9,27 հզր
Volume
0,00
52-wk high
8,31 $
52-wk low
4,63 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 մլն
No. of employees
217
News stories
From web sources and news partners
TradingView
·
1 ժամ առաջ
Dow, S&P 500, Nasdaq Futures Mixed As Traders Weigh AI Rebound, Await Inflation Data: HIMS, TTD, NVDA, MARA In Focus
Bloomberg.com
·
1 օր առաջ
Watch 95% S&P 500, 5% Bitcoin in New Franklin ETF: Drilldown
ChartMill
·
10 ժամ առաջ
Most-Active S&P 500 Stocks in Today's Session
24/7 Wall St.
·
10 ժամ առաջ
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersՀաքենսաք, Նյու Ջերսի, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websitechampionsoncology.com